We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2926
Acco Brands
ACCO
$423M
| $0 | ﹤0.01% |
23
-274
| -92% | -$2.27K |
2021 Q1
4 quarters
|
|
2927
Albertsons Companies
ACI
$6.32B
| – | – |
-11
| Closed | – | – |
|
2928
Axcelis
ACLS
$3.55B
| $0 | ﹤0.01% |
2
-6
| -75% | -$410 |
2021 Q4
1 quarter
|
|
2929
ADC Therapeutics
ADCT
$190M
| $0 | ﹤0.01% |
10
| – | – |
2021 Q1
4 quarters
|
|
2930
Addus HomeCare
ADUS
$2.18B
| – | – |
-3
| Closed | – | – |
|
2931
Agios Pharmaceuticals
AGIO
$1.93B
| – | – |
-9
| Closed | – | – |
|
2932
Agilon Health
AGL
$1.49B
| – | – |
-1
| Closed | -$515 | – |
|
2933
Agilysys
AGYS
$3.2B
| – | – |
-25
| Closed | -$1K | – |
|
2934
Ashford Hospitality Trust
AHT
$12M
| – | – |
-56
| Closed | -$5K | – |
|
2935
Applied Industrial Technologies
AIT
$12.3B
| – | – |
-11
| Closed | -$1K | – |
|
2936
Aimco
AIV
$244M
| $0 | ﹤0.01% |
1
| – | – |
2016 Q4
21 quarters
|
|
2937
Embotelladora Andina Series B
AKO.B
$4.57B
| – | – |
-1
| Closed | – | – |
|
2938
Alector
ALEC
$213M
| $0 | ﹤0.01% |
15
| – | – |
2021 Q1
4 quarters
|
|
2939
Allegiant Air
ALGT
$1.92B
| – | – |
-67
| Closed | -$11.3K | – |
|
2940
Altimmune
ALT
$459M
| $0 | ﹤0.01% |
54
-371
| -87% | -$2.73K |
2021 Q1
4 quarters
|
|
2941
Alexander's
ALX
$1.2B
| – | – |
-8
| Closed | -$2K | – |
|
2942
Octave Specialty Group
OSG
$207M
| $0 | ﹤0.01% |
16
-18
| -53% | -$244 |
2020 Q1
8 quarters
|
|
2943
Ardagh Metal Packaging
AMBP
$2.79B
| $0 | ﹤0.01% |
5
| – | – |
2021 Q4
1 quarter
|
|
2944
Amphastar Pharmaceuticals
AMPH
$1.12B
| $0 | ﹤0.01% |
13
-100
| -88% | -$2.84K |
2021 Q3
2 quarters
|
|
2945
Alpha Metallurgical Resources
AMR
$2.15B
| $0 | ﹤0.01% |
3
| – | – |
2019 Q1
12 quarters
|
|
2946
AMERISAFE
AMSF
$464M
| – | – |
-3
| Closed | – | – |
|
2947
DELISTED
American Woodmark
AMWD
| – | – |
-28
| Closed | -$2K | – |
|
2948
American Well
AMWL
$211M
| – | – |
-5
| Closed | -$1K | – |
|
2949
APi Group
APG
$17.4B
| $0 | ﹤0.01% |
20
+12
| +150% | +$176 |
2021 Q4
1 quarter
|
|
2950
Agora
API
$380M
| $0 | ﹤0.01% |
12
-7
| -37% | -$79 |
2021 Q4
1 quarter
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.